PMA

PMA can cause life-threatening side effects (such as hyperthermia and serotonin syndrome) even at moderate doses.

As a result, using this substance is strongly discouraged. It is also advised to always test your MDMA for the presence of PMA using a reagent testing kit as it is a common adulterant 1.

Also known as

Red mitsubishi, killer, death, pink ecstasy 2, Dr death, chicken powder, chicken yellow 1.

Classification

Central nervous system stimulant.

Overview

PMA/PMMA looks like, and is sold as ecstasy, but is more toxic, and in some cases fatal 2.

Para-methoxymethamphetamine (PMMA) is an analogue of para-methoxyamphetamine (PMA). Both are strong psychedelic/stimulants that are very similar to MDMA, MDA, MDEA and mescaline and likely to cause very strong, dangerous over-heating of the body. PMA has been available on the streets in the US since the 1970s, whereas PMMA has appeared on the UK streets more recently. They are usually found in ecstasy pills, or sold as ecstasy/MDMA pills with or without other amphetamines 2.

An empathogen with a slow onset and strong serotonin release. This, combined with its lack of dopamine release, often leads users to dose more for the pleasurable effects which reportedly do not appear. This often leading to hospitalisations and deaths. The drug has been missold as MDMA 3.

A potent hallucinogen substance of the amphetamine class. PMA belongs to a family of substances known as the substituted amphetamines. However, unlike other substituted amphetamines, PMA does not produce stimulant or entactogen effects, nor euphoria. It is not taken on its own but is instead found as an ingredient in tablets of “Ecstasy” as a false substitute for MDMA.

PMA has been around since the 1970s, where it was sold along with PMMA as ecstasy, and has gained great attention following a number of hospitalisations and deaths. It usually does not produce much noticeable effects, which leads to people ingesting more or combining it with other substances, until they eventually overdose. It produces dangerous adverse effects, including a sudden and extremely high rise in body temperature and blood pressure, abnormal heartbeats, dehydration and sometimes severe dizziness.

PMA, along with other drugs like PMMA and PMEA have very little recreational value and are considered as one of the most dangerous and toxic substances known. It is strongly recommended that these two drugs should be completely avoided 4.

Most people who take PMA or PMMA think they are taking MDMA. However, drugs sold as MDMA may not contain any MDMA at all. They can be a mix of amphetamines, PMA, PMMA, ketamine, NBOMe, methylone or other substances.

This is potentially harmful as PMA and PMMA have more toxic effects (and are less euphoric) than MDMA. It also takes longer to feel these effects, so people may take another pill in the mistaken belief that the first has not worked, sometimes resulting in overdose 5.

PMA and PMMA have been around since the 1970s and have been associated with a number of deaths over the years worldwide including in Australia. In 2012 and 2013 there was a spike in deaths directly attributable to PMA or PMMA in England and Wales 1, 6.

PMA, or paramethoxyamphetamine, is a synthetic hallucinogen often sold as ecstasy. It is sold in tablet, capsule and (rarely) powder form. PMA looks similar to ecstasy and costs about the same.

Those who take PMA often think they are taking ecstasy, which produces intensely pleasurable effects – including a boost in energy and empathy. People who use ecstasy say they experience feelings of closeness with others and a desire to touch others 7.

Medical usage

None.

What does it look like?

It is usually found in pill form, a white-ish colour, but can also be pink or yellow.

Several PMA pills have been found to have a Mitsubishi stamp imprinted on them 2.

PMA/PMMA looks like, and is often sold as MDMA. Which means they are often found in tablet or capsule form and will come in different colours and sizes with different pictures, symbols or logos 1.

Pure PMA is a white powder, but street products can also be beige, pink or yellowish. Today it is usually made into pressed pills 8.

Paramethoxyamphetamine (PMA) and paramethoxymethamphetamine (PMMA) can be in powdered form although they are rarely seen as a street drug in the UK as they are have few desirable effects but are extremely dangerous and toxic. A decade ago, PMA and PMMA were responsible for a number of UK deaths when they were mis-sold as ecstasy pills 9

Source

PMA first came into circulation in the early 1970s, where it was used as a substitute for the hallucinogenic properties of LSD. PMA and PMMA are produced in illicit labs 9

Prevalence

PMMA has been found recently in pale blue ecstasy tablets in Scotland where they are known as “Einsteins” which have an “E=mc2” logo. Not all batches of Einsteins have contained PMMA, some have contained MDMA so even where users have used before with no problems, this cannot be guaranteed the next time they use 10.

Why take it?

Sought after effects

Effects are similar to those experienced with other stimulants including ecstasy and other amphetamines:

  • increase in energy,
  • minor visuals 2.

Undesired effects

Symptoms with a higher dose include:

  • hallucinations,
  • convulsions,
  • respiratory distress 2.

Dosage

Abuse

  • Doses of less than 50 milligrams (usually one pill) causes symptoms like ecstasy; increased breathing, body temperature, pulse rate and blood pressure, erratic eye movements, muscle spasms, nausea and heightened visual stimulation.
  • Dosages over 60-80 mg (lower than those used regularly for ecstasy) are considered potentially lethal. They can cause cardiac arrhythmia (irregular heartbeat) and arrest, breathing problems, pulmonary congestion, kidney failure, hypothermia, vomiting, convulsions, coma and death 11.

Pharmacology

PMA strongly acts as a selective serotonin releasing agent (SSRA) and very weakly on dopamine and norepinephrine (noradrenaline) systems in the brain and nervous system. However, it is not as potent in directly releasing serotonin in the same way as MDMA, and consequently is not particularly euphoric. Studies show that rodents do not seem to self-administer it in the same way as they do amphetamine and MDMA.

The other great difference between PMA/PMMA and other amphetamine-type substances is its inhibitory effect on the enzyme monoamine oxidase (MAO). It is 20 times more potent on this enzyme (specifically the ‘A’ variant) than amphetamine. MAO acts to breakdown compounds such as serotonin, dopamine, norepinephrine and epinephrine in the liver. This prevents toxic and potentially lethal levels of these ‘monoamines’ from building up in the blood. Although not fully understood, it is thought that the reason PMA and PMMA are fatal is due to a combination of this inhibitory effect on the MAO-A enzyme in preventing the metabolism of monoamines as well as an increase in serotonin centrally that causes the body to overheat 2.

PMA acts as a selective serotonin releasing agent (SSRA) with weak effects on dopamine and norepinephrine transporters. However, relative to MDMA, it is considerably less effective as a releaser of serotonin with properties more akin to a reuptake inhibitor in comparison. It evokes robust hyperthermia while producing only modest hyperactivity and serotonergic neurotoxicity, substantially lower than that caused by MDMA. Anecdotal reports suggest it is not particularly euphoric at all, perhaps even dysphoric in contrast. PMA has also been shown to act as a potent, reversible inhibitor of the enzyme MAO-A with no significant effects on MAO-B, and the combination of this property and serotonin release is likely responsible for its high lethality potential.

It appears that PMA elevates body temperatures dramatically; the cause of this property is suspected to be related to its ability to inhibit MAO-A and at the same time releasing large amounts of serotonin, effectively causing serotonin syndrome. It appears that PMA activates the hypothalamus much more strongly than MDMA and other drugs like ephedrine, thereby causing rapid increases in body temperature (which is the major cause of death in PMA mortalities) 4.

It is structurally similar to methamphetamine and paramethoxyamphetamine (PMA) 12.

Mode of use

Swallowed: pills are swallowed (ingested) 2.

Usually swallowed and can also be snorted or injected 1.

Usually swallowed in a pill mis-sold as ecstasy 9.

Signs of usage

These include erratic eye movements, muscle spasms, nausea and heightened visual stimulation 11. Symptoms after ingestions can be pupil dilation, increase in body temperature, nausea and vomiting. In some cases ingestion can lead to convulsions, coma and death 8.

Effects

Use of any drug can have risks. It’s important to be careful when taking any type of drug.

PMA and PMMA affect everyone differently, based on:

  • size, weight and health,
  • whether the person is used to taking it,
  • whether other drugs are taken around the same time,
  • the amount taken,
  • the strength of the drug (varies from batch to batch),
  • the environment (where the drug is taken) 1.

Desired effects

PMA and PMMA as they are not considered to have any recreational value as they produce only mild stimulant and euphoric effects and moderate visual distortions. However, it is thought most people who have used these drugs purchased them believing they were MDMA pills. PMMA is reportedly weaker than PMA but more “ecstasy-like” 9.

Long-term effects

The long-term effects of PMA and PMMA have not yet been established but some research indicates they may have similar long-term effects to ecstasy 1, 13.

Physical effects

  • Stimulation – In terms of its effects on the user’s physical energy levels, PMA is commonly regarded as moderately stimulating and energetic exclusively at lower dosages.
  • Abnormal heartbeat – Accelerated and abnormal heartbeats are extremely common with PMA.
  • Appetite suppression.
  • Dehydration.
  • Dizziness – This effect is significantly more common with PMA than it is with methamphetamine or MDMA 4.
  • Dry mouth.
  • Heightened senses (sight, hearing and touch) 1.
  • Increased bodily temperature – The most common cause of death from PMA is due to severe hyperthermia.
  • Increased blood pressure.
  • Increased heart rate.
  • Increased perspiration 4.
  • Muscle spasms 1.
  • Nausea and vomiting – This is common at any dose.
  • Pupil dilation.
  • Rapid breathing – People commonly report “not being able to breathe”.
  • Seizures – This is significantly more common with PMMA than with almost any other substance.
  • Teeth grinding.
  • Temporary erectile dysfunction.
  • Vasoconstriction.
  • Vibrating vision – This effect is generally more frequent than with MDMA 4.

Cognitive effects

  • Anxiety or Anxiety suppression – This depends greatly on the dosage, as higher dosages are almost guaranteed to bring anxiety, due to all the adverse effects.
  • Cognitive euphoria or cognitive dysphoria – This depends greatly on the dosage, as higher dosages are almost guaranteed to bring dysphoria, due to all the adverse effects.
  • Dream suppression.
  • Time distortion.
  • Wakefulness 4.

Visual effects

At moderate to high dosages, PMA is capable of producing typically mild or moderate visual distortions, which are usually more common and pronounced than with MDMA, but significantly less when compared with most psychedelics, such as 2C-B or LSD 4.

  • Seeing colours and shapes.
  • Irregular eye movements 1

Suppressions

  • Double vision 4.

Distortions

  • Drifting (melting, breathing, morphing and flowing) – This effects is more pronounced than it is with MDMA.
  • Tracers 4.

Side-effects

  • Abnormal heartbeat
  • Appetite suppression
  • Dehydration
  • Dizziness
  • Increased body temperature, blood pressure and heart rate
  • Increased perspiration
  • Nausea and vomiting
  • Rapid breathing
  • Seizures
  • Teeth grinding
  • Vasoconstriction
  • Vibrating vision
  • Anxiety
  • Double vision

Coming down

In the days after using PMA/PMMA, you may experience:

  • difficulty concentrating,
  • anxiety, irritability and depression,
  • restless sleep and exhaustion,
  • loss of appetite,
  • paranoia (feeling suspicious and frightened) 1, 14.

Overdose

If you take a large amount or have a strong batch, you could overdose.

PMA and PMMA can cause death. Call an ambulance straight away by dialling 999 or triple zero (000) if you, or someone else, has any of the following symptoms (Emergency services are there to help and can provide instructions over the phone):

  • extremely high body temperature,
  • convulsions and seizures,
  • difficulty breathing,
  • nausea and vomiting,
  • kidney failure,
  • severe hyperthermia,
  • coma 1, 15.

Tolerance and dependence

It is possible to build up a tolerance to PMA/PMMA, which means you need to take larger amounts of it to get the same effect. However, there have been no reports of any physical withdrawal symptoms and dependence. There is potential for psychological dependence to develop (desire to keep taking the drug despite the risks) 1, 16, 17.

Risks

Short-term

PMA and PMMA are less euphoric but more toxic at lower doses than MDMA and can also take longer to take effect. This has led people to believe they were taking low dose MDMA pills and redosing leading to overdose. They can cause life-threatening hyperthermia and serotonin syndrome even at moderate doses. Risks are increased if mixed with other stimulant drugs or with alcohol 9.

Long-term

Long term risks are not yet fully known 9.

Dangerous interactions

PMA and its relative PMMA can be considered extremely toxic when compared to other substances such as methamphetamine or MDMA. Ingestion of PMA has been associated with severe tachycardia (abnormally high heart rate), seizures, dehydration, hyperthermia, and death. PMA has a relatively slow onset, causing many users to redose which causes excess toxicity.

Dangerous

  • Alcohol – Drinking alcohol on stimulants is considered risky because it reduces the sedative effects of the alcohol that the body uses to gauge drunkenness. This often leads to excessive drinking with greatly reduced inhibitions, increasing the risk of liver damage and increased dehydration. The effects of stimulants will also allow one to drink past a point where they might normally pass out, increasing the risk. If you do decide to do this then you should set a limit of how much you will drink each hour and stick to it, bearing in mind that you will feel the alcohol and the stimulant less.
  • GHB/GBL – Stimulants increase respiration rate allowing a higher dose of sedatives. If the stimulant wears off first then the depressant effects of the GHB/GBL may overcome the user and cause respiratory arrest.
  • Opioids – Stimulants increase respiration rate allowing a higher dose of opiates. If the stimulant wears off first then the opiate may overcome the patient and cause respiratory arrest.
  • Cocaine – The rewarding effects of cocaine are mediated by DAT inhibition, and an increase of exocytosis of dopamine through the cell membrane. Amphetamine reverses the direction of DAT and the direction vesicular transports within the cell by a pH mediated mechanism of displacement, thus excludes the regular mechanism of dopamine release through means of exocytosis because the effects Na+/K+ ATPase are inhibited. You will find cardiac effects with the combination of cocaine and amphetamine due to a SERT mediated mechanism from the subsequent activation of 5-HT2B, which is an effect of serotonin-related valvulopathy. Amphetamines generally cause hypertension in models of abuse, and this combination can increase the chances of syncope due to turbulent blood flow during valve operation. The rewarding mechanisms of cocaine are reversed by administration of amphetamine 18 , 19 , 20.
  • Cannabis – Stimulants increase anxiety levels and the risk of thought loops and paranoia which can lead to negative experiences.
  • Caffeine – This combination of stimulants is generally considered unnecessary and may increase strain on the heart, as well as potentially causing anxiety and physical discomfort.
  • Tramadol – Tramadol and stimulants both increase the risk of seizures.
  • DXM – Both substances raise heart rate, in extreme cases, panic attacks caused by these substances have led to more serious heart issues.
  • Ketamine – Combining amphetamine and ketamine may result in psychoses that resemble schizophrenia, but not worse than the psychoses produced by either substance alone, but this is debatable. This is due to amphetamines ability to attenuated the disruption of working memory caused by ketamine. Amphetamine alone may result in grandiosity, paranoia, or somatic delusions with little to no effect on negative symptoms. Ketamine, however, will result in thought disorders, disruption of executive functioning, and delusions due to a modification of conception. These mechanisms are due to an increase of dopaminergic activity in the mesolimbic pathway caused by amphetamine due to its pharmacology effecting dopamine, and due to a disruption of dopaminergic functioning in the mesocortical pathways via NMDA antagonism effects of ketamine. Combining the two, you may expect mainly thought disorder along with positive symptoms 19.
  • PCP – Increases risk of tachycardia, hypertension, and manic states.
  • Methoxetamine – Increases risk of tachycardia, hypertension, and manic states.
  • Psychedelics (e.g. LSD, mescaline, psilocybin) – Increases risk of anxiety, paranoia, and thought loops.
    • 25x-NBOMe – Amphetamines and NBOMes both provide considerable stimulation that when combined they can result in tachycardia, hypertension, vasoconstriction and, in extreme cases, heart failure. The anxiogenic and focusing effects of stimulants are also not good in combination with psychedelics as they can lead to unpleasant thought loops. NBOMes are known to cause seizures and stimulants can increase this risk.
    • 2C-T-x – Suspected of mild MAOI properties. May increase the risk of hypertensive crisis.
    • 5-MeO-xxT – Suspected of mild MAOI properties. May increase the risk of hypertensive crisis.
    • DOx
  • aMT – aMT has MAOI properties which may interact unfavorably with amphetamines.
  • MAOIs – MAO-B inhibitors can increase the potency and duration of phenethylamines unpredictably. MAO-A inhibitors with amphetamine can lead to hypertensive crises.

Legality

  • PMA is a Class A drug and is illegal to have, give away or sell.
  • Schedule 1

What if you’re caught?

  • Possession
    • Maximum sentence – 7 years imprisonment, a fine, or both.
  • Possession With Intent To Supply
    • Maximum sentence – life imprisonment, a fine, or both.
  • Supply (including being concerned in supply, conspiracy to supply, aggravated supply and offer to supply)
    • Maximum sentence – life imprisonment, a fine, or both.
  • Production.
    • Maximum sentence – life imprisonment, a fine, or both 2.

In practice maximum sentences are rarely used 2.

Harm reduction

There have been a number of deaths caused by PMMA/PMA over the last few decades. The exact numbers are not clear, but the deaths seem to be rising.

The predominant symptom of the fatalities has been hyperthermia (overheating of the body) and the causes of death since around 2010 have been related to either PMA or PMMA.

Most recently,there have been four deaths in the UK where PM(M)A was thought to be the cause 2.

There are ways you can reduce the risk of harm when taking PMA/PMMA:

  • Start with a lower dose first and wait 2 hours before taking any more.
  • Avoid taking higher does of PMA/PMMA. This has been known to be lethal.
  • Avoid using if you have an existing heart condition, blood pressure problems, epilepsy or asthma.
  • Avoid mixing with other drugs.
  • Drinking too much water while taking PMA/PMMA is dangerous but it is also important to maintain hydration. If dancing, take regular breaks to cool down and drink around 250-500ml of water per hour 1, 21.

Drug potency

This is very hard to estimate with tablets, but here are a few things to consider:

  • What are the markings on tablets that are being offered around? Make sure you can see what you are taking.
  • ‘Ramps’ or marks on tabs are no guarantee of content, but they can help guide you.
  • Colour and size or texture can help to identify a tablet, but producers rely on a type of brand recognition that can work on a number of levels.
  • Just because one type of pill say a ‘white dove’, for example, was good a couple of months ago, doesn’t mean you can rely on it now.
  • Check the websites that offer information. These days, ‘smartphones’ offers an extra level of self-protection that was not available to people at clubs previously. But the same advice applies, perhaps the best way to look at it is – you are looking for reports of bad pills, not necessarily endorsements of good ones.
  • If you can, get your pills tested before taking them. If they include PMA/PMMA do not take the pills 2.

Staying safe

Remember that if you don’t feel any effect from one pill (at the most) after 45 minutes, it is possible that you have not taken MDMA. Taking more of the same will not help. If it is PMA/PMMA you are taking a significant risk.

The possible interaction with other substances particularly alcohol and alcohol/energy drink mixes; if you are doing pills these should be avoided 2.

Setting: This means the environment that you are in. While you are out to have a good time, don’t get too lost in the moment. It is particularly important to be aware that your body will be more likely to overheat if you are dancing in a packed club and you should make sure you top up on liquids, particularly water or an ‘isotonic’ beverage. The recommended guidelines are sipping 500ml/hour (when dancing) or 250ml/hour (when inactive) of water. However, be cautious of consuming over this amount as it can lead to overhydration which can be fatal.

Overheating is a cause for concern as one of the symptoms of PMA/PMMA at dangerous doses is hyperthermia. If you are in a club, do not try to counter-balance this by going out immediately to cool down, a sudden drastic change in environment can be risky. You will want to get somewhere more temperate, but overheating with PMA/PMMA does not only occur in clubs, it is an internal physical reaction. If you are worried and you begin to overheat, call an ambulance.

Stay together with your mates for at least an hour if you do take any pills.

Make sure you know where your trusted friends are if you are at a big rave, and if you get separated, have a meet-up point. If you are in other social settings (i.e. not raves or nightclubs) and you or someone who know shows signs of overheating, it is advisable to be cautious that you have taken PMA/PMMA and you should seek medical help 2.

Paraphernalia

None.

History

PMA has been present in the drugs market since 1970. The first deaths reported by the U.S. due to the substance being mis-sold as MDA, were in 1972. Around this time (1975), the substance was being sold as a recreational psychoactive under the name “chicken powder” and “chicken yellow”.

The substance then began to drop in circulation from the market in the 1980s, with only a few deaths being reported between the late 1970s and the very early 1990s. However, in the early 1990s there was a rise in deaths again as the substance began to reappear in Australia. Since then, the pill has been dropping in use, and resurfacing in the illicit market every so often. In 2000-2001 there were nearly 20 deaths across the world due to PMA/PMMA being mis-sold as ecstasy pills.

In late 2010, over a course of 6 months there were 12 deaths in Norway that were found to be caused by PMMA. This first brought PMMA into mainstream media attention.

In 2013 we saw a rise in deaths occurring in the UK, again due to PMA/PMMA being mis-sold as ecstasy pills 2.

Footnotes:

5

Department of Health, 2026, MDMA adulterated with PMMA: Victoria Government; 2022.

6

Office for National Statistics, 2026, Deaths Related to Drug Poisoning in England and Wales: 2012: Office for National Statistics.

13

Expert Committee on Drug Dependence. para-Methoxymethylamphetamine (PMMA): Critical Review Report: World Heath Ogranization

14

Black E, Shakeshaft A, Newton N, Teesson M, Farrell M, Rodriguez D. Party Drugs/MDMA/Ecstasy – What you need to know. UNSW Sydney: National Drug and Alcohol Research Centre; 2017

15

National Drug and Alcohol Research Centre, 2026, Paramethoxyamphetamine (PMA) 2016.

18

Greenwald, M. K., Lundahl, L. H., Steinmiller, C. L. (December 2010). Sustained Release d-Amphetamine Reduces Cocaine but not ‘Speedball’-Seeking in Buprenorphine-Maintained Volunteers: A Test of Dual-Agonist Pharmacotherapy for Cocaine/Heroin Polydrug Abusers. Neuropsychopharmacology. 35 (13): 2624-2637. https://doi.org/10.1038/npp.2010.175. ISSN 0893-133X.

19

Siciliano, C. A., Saha, K., Calipari, E. S., Fordahl, S. C., Chen, R., Khoshbouei, H., Jones, S. R. (10 January 2018). Amphetamine Reverses Escalated Cocaine Intake via Restoration of Dopamine Transporter Conformation. The Journal of Neuroscience. 38 (2): 484-497. https://doi.org/10.1523/JNEUROSCI.2604-17.2017. ISSN 0270-6474.